Related references
Note: Only part of the references are listed.Convenient synthesis, antimalarial and antimicrobial potential of thioethereal 1,4-disubstituted 1,2,3-triazoles with ester functionality
C. P. Kaushik et al.
MEDICINAL CHEMISTRY RESEARCH (2018)
Current advances in drug discovery for Chagas disease
Caue Benito Scarim et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi
Gevanio Bezerra de Oliveira Filho et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Biological factors that impinge on Chagas disease drug development
Amanda F. Francisco et al.
PARASITOLOGY (2017)
Compound profiling and 3D-QSAR studies of hydrazone derivatives with activity against intracellular Trypanosoma cruzi
Livia Bandeira Costa et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
New 1,3-thiazole derivatives and their biological and ultrastructural effects on Trypanosoma cruzi
Paulo Andre Teixeira de Moraes Gomes et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Structural design, synthesis and pharmacological evaluation of 4-thiazolidinones against Trypanosoma cruzi
Gevanio Bezerra de Oliveira Filho et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Synthesis and structure-activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain
Jose Wanderlan Pontes Espindola et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Chagas Disease Drug Discovery: Toward a New Era
Eric Chatelain
JOURNAL OF BIOMOLECULAR SCREENING (2015)
Structural Design, Synthesis and Structure-Activity Relationships of Thiazolidinones with Enhanced Anti-Trypanosoma cruzi Activity
Diogo Rodrigo Magalhaes Moreira et al.
CHEMMEDCHEM (2014)
2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: Structural design, synthesis and pharmacological evaluation
Marcos Verissimo de Oliveira Cardoso et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death
Diogo Rodrigo Magalhaes Moreira et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
The present situation, challenges, and perspectives regarding the production and utilization of effective drugs against human Chagas disease
Joao Carlos Pinto Dias et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2014)
Human Chagas Disease and Migration in the Context of Globalization: Some Particular Aspects
Joao Carlos Pinto Dias
JOURNAL OF TROPICAL MEDICINE (2013)
Structural Investigation of Anti-Trypanosoma cruzi 2-Iminothiazolidin-4-ones Allows the Identification of Agents with Efficacy in Infected Mice
Diogo Rodrigo Magalhaes Moreira et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety
Nicholas A. Meanwell
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
Studies toward the structural optimization of novel thiazolylhydrazone-based potent antitrypanosomal agents
Marcelo Zaldini Hernandes et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Second Generation Analogues of the Cancer Drug Clinical Candidate Tipifarnib for Anti-Chagas Disease Drug Discovery
James M. Kraus et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Rational Modification of a Candidate Cancer Drug for Use Against Chagas Disease
James M. Kraus et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain
XH Du et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Share Paper
